Table 2.
Clinical characteristics of 96 patients infected with influenza and respiratory syncytial virus in the respiratory surveillance cohort.
| Flu | RSV | ||||||
|---|---|---|---|---|---|---|---|
| N Response | N Positive or Mean | % or s.d. | N Response | N Positive or Mean | % or s.d. | p-Value | |
| Age group | |||||||
| Adult (15–59 years) | 45 | 37 | 82.22% | 51 | 23 | 45.10% | <0.001 |
| Elderly (60+ years) | 45 | 8 | 17.78% | 51 | 28 | 54.90% | |
| Mean age (years) | 45 | 39.42 | 19.13 | 51 | 59.20 | 18.21 | <0.001 |
| Sex | |||||||
| Female | 45 | 21 | 46.67% | 51 | 26 | 50.98% | 0.673 |
| Male | 45 | 24 | 53.33% | 51 | 25 | 49.02% | |
| Ethnicity | |||||||
| White | 41 | 37 | 90.24% | 51 | 46 | 90.20% | 0.894 |
| Black | 41 | 3 | 7.32% | 51 | 3 | 5.88% | |
| Mixed race | 41 | 1 | 2.44% | 51 | 2 | 3.92% | |
| Education | |||||||
| Primary incomplete | 38 | 7 | 18.42% | 46 | 26 | 56.52% | 0.002 |
| Primary | 38 | 0 | 0.00% | 46 | 0 | 0.00% | |
| High school | 38 | 15 | 39.47% | 46 | 9 | 19.57% | |
| College | 38 | 16 | 42.11% | 46 | 11 | 23.91% | |
| Comorbidities | 38 | 18 | 47.37% | 49 | 39 | 79.59% | <0.001 |
| Cardiopathy | 38 | 1 | 2.63% | 49 | 14 | 28.57% | <0.001 |
| Blood pressure | 38 | 7 | 18.42% | 49 | 19 | 38.78% | 0.024 |
| Hematological disease | 38 | 0 | 0.00% | 49 | 2 | 4.08% | 0.499 |
| Down syndrome | 38 | 0 | 0.00% | 49 | 2 | 4.08% | 0.499 |
| Liver disease | 38 | 0 | 0.00% | 49 | 6 | 12.24% | 0.300 |
| Asthma | 38 | 1 | 2.63% | 49 | 0 | 0.00% | 0.452 |
| Diabetes | 38 | 4 | 10.53% | 49 | 13 | 26.53% | 0.044 |
| Neurovascular disease | 38 | 0 | 0.00% | 49 | 6 | 12.24% | 0.030 |
| Neurological disease | 38 | 0 | 0.00% | 49 | 5 | 10.20% | 0.061 |
| Pneumopathy | 38 | 1 | 2.63% | 49 | 5 | 10.20% | 0.215 |
| Immunosuppression | 38 | 0 | 0.00% | 48 | 1 | 2.08% | 1 |
| Kidney disease | 38 | 0 | 0.00% | 49 | 6 | 12.24% | 0.030 |
| Obesity | 38 | 1 | 2.63% | 49 | 3 | 6.12% | 0.623 |
| Smoker | 35 | 6 | 17.14% | 41 | 7 | 17.07% | 1 |
| Cancer | 38 | 4 | 10.53% | 49 | 5 | 10.20% | 1 |
| Signs and symptoms | |||||||
| Fever | 37 | 22 | 59.46% | 42 | 16 | 38.10% | 0.058 |
| Headache | 37 | 17 | 45.95% | 42 | 9 | 21.43% | 0.021 |
| Myalgia | 37 | 19 | 51.35% | 42 | 8 | 19.05% | 0.003 |
| Nasal congestion | 37 | 21 | 56.76% | 42 | 10 | 23.81% | 0.003 |
| Cough | 37 | 29 | 78.38% | 42 | 30 | 71.43% | 0.478 |
| Sore throat | 37 | 15 | 40.54% | 42 | 4 | 9.52% | <0.001 |
| Dyspnea | 37 | 4 | 10.81% | 42 | 16 | 38.10% | 0.005 |
| Respiratory distress | 37 | 1 | 2.70% | 42 | 15 | 35.71% | <0.001 |
| Diarrhea | 37 | 2 | 5.41% | 42 | 4 | 9.52% | 0.679 |
| Vomiting | 37 | 0 | 0.00% | 42 | 1 | 2.38% | 1 |
| Abdominal pain | 37 | 3 | 8.11% | 42 | 2 | 4.76% | 0.661 |
| Malaise | 37 | 8 | 21.62% | 42 | 15 | 35.71% | 0.169 |
| Loss of smell | 37 | 1 | 2.70% | 42 | 0 | 0.00% | 0.468 |
| Loss of taste | 37 | 1 | 2.70% | 42 | 0 | 0.00% | 0.468 |
| Hospitalization | 45 | 45 | 100.00% | 51 | 51 | 100.00% | NA |
| ICU | 42 | 1 | 2.38% | 51 | 5 | 9.80% | 0.217 |
| Ventilatory support | 42 | 4 | 9.52% | 50 | 23 | 46.00% | <0.001 |
| Death | 43 | 8 | 18.60% | 46 | 15 | 32.61% | 0.132 |